Michael Mauro Discusses Therapy-Free CML Remission

Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission. 

Mauro says patients with CML are often concerned about how long they have to stay on medication.